960 resultados para Illinois Stroke Task Force


Relevância:

100.00% 100.00%

Publicador:

Resumo:

This report of the Independent Charter School Authorizer Task Force is respectfully submitted to the Governor and the Illinois General Assembly. The task force recommends that the existing state charter school law be modified in order to improve the quality of charter school authorization throughout the state.

Relevância:

100.00% 100.00%

Publicador:

Resumo:

Cover title.

Relevância:

100.00% 100.00%

Publicador:

Resumo:

"In accordance with PA 093-0773."

Relevância:

100.00% 100.00%

Publicador:

Resumo:

On cover: Chemical safety.

Relevância:

100.00% 100.00%

Publicador:

Resumo:

Pursuant to Senate Joint Resolution 83, the Task Force studied the problems of persons released from prison and made recommendations for the solution of these problems.

Relevância:

100.00% 100.00%

Publicador:

Resumo:

The Task Force was charged with exploring the causes and consequences of bullying in schools in this State, identifying promising practices that reduce incidences of bullying, highlighting training and technical assistance opportunities for schools to effectively address bullying, evaluating the effectiveness of schools current anti-bullying policies and other bullying prevention programs, and other related issues. Under tight time constraints, the Task Force has met that change. The Illinois State Board of Education will post this report on its webpage devoted to the Task Force (http://www.isbe.net/SBPTF/default.htm). Moreover in the near future, the Task Force will produce an Executive Summary of this report which the ISBE will also include on the Task Force webpage.

Relevância:

100.00% 100.00%

Publicador:

Resumo:

" ... submitted in compliance with Public Act 94-0225."

Relevância:

100.00% 100.00%

Publicador:

Resumo:

"April 2006."

Relevância:

100.00% 100.00%

Publicador:

Resumo:

Mycosis fungoides (MF) and Sezary syndrome (SS), the major forms of cutaneous T-cell lymphoma, have unique characteristics that distinguish them from other types of non-Hodgkin`s lymphomas. Clinical trials in MF/SS have suffered from a lack of standardization in evaluation, staging, assessment, end points, and response criteria. Recently defined criteria for the diagnosis of early MF, guidelines for initial evaluation, and revised staging and classification criteria for MF and SS now offer the potential for uniform staging of patients enrolled in clinical trials for MF/SS. This article presents consensus recommendations for the general conduct of clinical trials of patients with MF/SS as well as methods for standardized assessment of potential disease manifestations in skin, lymph nodes, blood, and visceral organs, and definition of end points and response criteria. These guidelines should facilitate collaboration among investigators and collation of data from sponsor-generated or investigator-initiated clinical trials involving patients with MF or SS. J Clin Oncol 29:2598-2607. (C) 2011 by American Society of Clinical Oncology